Two Supplements May Strengthen Hep C Antiviral Treatment
Although many have heard of the supplements SAMe and betaine, their potential benefits to those on Hepatitis C treatment are not yet widely known.
Continue reading »Research & Treatment News
Share
Follow Us
Early Hepatitis C Trial Data Shows INX-189 to Be Effective
Interim data from a Phase 1b trial of Inhibitex's INX-189 demonstrates potent antiviral activity against the Hepatitis C virus.
Continue reading »Boceprevir Officially Fast-Tracked
In the U.S. and Europe, Boceprevir's entrance into the market is being accelerated due to its effectiveness against Hepatitis C.
Continue reading »IP-10 Protein Levels Predict Hepatitis C Treatment Outcome
Investigators have discovered that blood levels of a specific protein appear to foretell of Hepatitis C treatment success or failure.
Continue reading »Update on Pharmasset's Hepatitis C Drug Candidates
Pharmasset has released interim study results for several of its Hepatitis C drugs that are in different stages of testing.
Continue reading »Hepatitis C Drug ANA598 Moves to Phase IIb
Along with Health Canada, the United States Food and Drug Administration has cleared the protocol for Anadys' Phase IIb Hepatitis C study of ANA598 in combination with pegylated interferon and ribavirin.
Continue reading »Hep C Advisory: Where Salt Hides
Also known as salt, sodium is overly abundant in many common foods - an abundance that could put someone with advanced Hepatitis C infection in peril.
Continue reading »Hepatitis C Protein Interaction Identified
Scripps researchers have identified a protein that interacts with the Hepatitis C virus to enable replication. Since blocking this interaction could impair the virus' ability to reproduce, Scripps' discovery could lead to a new focus for the next generation of Hepatitis C drugs.
Continue reading »FDA Prioritizes Hepatitis C
In order for our society to overcome the burden of Hepatitis C, we must prioritize efforts to increase its awareness, detection and treatment. Moving along those lines, the FDA makes an important step in that direction.
Continue reading »Developmental Hep C Drug Gets Good Initial Marks
Designed to stimulate the immune system so the body can produce its own natural interferon, Idera's IMO-2125 posted great results from its Hepatitis C Phase 1 trial.
Continue reading »
